Complete Remission With Partial Hematological Recovery as a Palliative Endpoint in Clinical Trials for AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Complete Remission with Partial Hematological Recovery as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia
Blood 2024 May 10;[EPub Ahead of Print], RQ Le, D Przepiorka, H Chen, YL Shen, ED Pulte, KJ Norsworthy, MR Theoret, RA De ClaroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.